Muscle Reflex Inhibition in Hypoxic Exercise
Effect of Muscle Reflex Inhibition on Cardiorespiratory Responses to Exercise in Hypoxia
1 other identifier
interventional
14
1 country
1
Brief Summary
The goal of this interventional study is to compare muscle reflex function under settings of normoxia (normal oxygen level), acute hypoxia (brief oxygen-lack) and chronic hypoxia (long-duration exposure to oxygen-lack). The main question is: Does the muscle reflex adapt to chronic hypoxia? Young, healthy participants will complete light-to-high intensity cycling exercise with and without suppression of the muscle reflex. Suppression of the muscle reflex will be via spinal administration of the opioid Fentanyl. In the control condition, saline will be administered into the spinal space. Participants will complete control (saline) and experimental (Fentanyl) exercise conditions at sea-level (Kelowna, BC, Canada) breathing room air and whilst breathing a lower fraction of oxygen (acute hypoxia). Thereafter, participants will complete the exercise test after living at high altitude (White Mountain, CA, USA) for 2 weeks whilst breathing room air (chronic hypoxia) and breathing a higher fraction of oxygen (restored normoxia).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2022
CompletedFirst Posted
Study publicly available on registry
November 17, 2022
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedNovember 23, 2022
November 1, 2022
6 months
November 9, 2022
November 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ventilation
Ventilation, in liters per minute.
Data collected during steady-state breathing in the last minute of exercise
Secondary Outcomes (1)
Mean arterial blood pressure (entire pressure wave)
Data collected during steady-state breathing in the last minute of exercise
Other Outcomes (1)
Exercise performance
The duration, i.e., however long it takes to complete the exercise; this is typically 7-14 minutes
Study Arms (4)
Sea level control
PLACEBO COMPARATORSea level exercise will be completed after the administration of 1 mL of isotonic saline into the intrathecal (spinal) space between L3-L4.
Sea level experimental (muscle reflex suppression)
EXPERIMENTALSea level exercise will be completed after the administration of 0.25 mL of fentanyl into the intrathecal (spinal) space between L3-L4.
High altitude control
PLACEBO COMPARATORHigh altitude exercise will be completed after the administration of 1 mL of isotonic saline into the intrathecal (spinal) space between L3-L4.
High altitude experimental (muscle reflex suppression)
EXPERIMENTALHigh altitude exercise will be completed after the administration of 0.25 mL of fentanyl into the intrathecal (spinal) space between L3-L4.
Interventions
Fentanyl, when administered into the intrathecal (spinal) space suppresses feedback from the muscles below the site of action, i.e., the legs. It does not affect resting cardiorespiratory responses. We are using this to test what role the muscle reflex plays during exercise.
An equal volume (as above) of saline will be administered into the intrathecal (spinal) space. This has no effect of cardiorespiratory responses at rest or during exercise; it is to control for the invasiveness of the procedure required to suppress muscle feedback in the experimental condition.
Eligibility Criteria
You may qualify if:
- aged 19 - 40 years old
- not taking medications (exception oral contraception)
- no history of cardiovascular, respiratory or neurological disease
- members of the high altitude expedition to White Mountain in 2023
You may not qualify if:
- post-menopausal or pregnant
- obese
- current smokers
- taking prescription medications that may affect responses to exercise
- All potential participants will be screened by a physician to identify co-morbidities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of British Columbia - Okanagan Campus
Kelowna, British Columbia, V1V1V7, Canada
Related Publications (2)
Amann M, Proctor LT, Sebranek JJ, Pegelow DF, Dempsey JA. Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans. J Physiol. 2009 Jan 15;587(1):271-83. doi: 10.1113/jphysiol.2008.163303. Epub 2008 Nov 17.
PMID: 19015193RESULTWan HY, Weavil JC, Thurston TS, Georgescu VP, Bledsoe AD, Jessop JE, Buys MJ, Richardson RS, Amann M. The muscle reflex and chemoreflex interaction: ventilatory implications for the exercising human. J Appl Physiol (1985). 2020 Oct 1;129(4):691-700. doi: 10.1152/japplphysiol.00449.2020. Epub 2020 Aug 20.
PMID: 32816637RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philip N Ainslie, PhD
University of British Columbia- Okanagan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The participant will not know whether they are receiving placebo or fentanyl. The primary investigator will also no know if the participant is receiving placebo or fentanyl.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 9, 2022
First Posted
November 17, 2022
Study Start
June 1, 2023
Primary Completion
December 1, 2023
Study Completion
June 1, 2024
Last Updated
November 23, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share
No personal data will be made available publicly or to other researchers.